Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

208
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
208
Model Approaches for Pharmacokinetic Data: Physiological Models01:15

Model Approaches for Pharmacokinetic Data: Physiological Models

222
Physiological models in pharmacokinetics are instrumental in understanding the distribution and elimination of drugs within the body. These models describe the drug concentration within target organs, influenced by factors such as drug uptake, tissue volume, and blood flow. Drug uptake is governed by the partition coefficient, which signifies the drug concentration ratio in tissue to that in the blood. The blood flow rate to a specific tissue is expressed as Qt, and the rate of change in tissue...
222
Multicompartment Models: Overview01:14

Multicompartment Models: Overview

456
Multicompartment models are mathematical constructs that depict how drugs are distributed and eliminated within the body. They segment the body into several compartments, symbolizing various physiological or anatomical areas connected through drug transfer processes such as absorption, metabolism, distribution, and elimination.
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
456
End Point Prediction: Gran Plot01:07

End Point Prediction: Gran Plot

1.1K
A Gran plot is used to predict the equivalence volume or endpoint of a potentiometric or acid-base titration without reaching the endpoint. Typically, titration data is collected as a function of the titrant's volume up to a point less than the equivalence volume and then transformed into a linear format. The straight line is extended to the x-axis, indicating the necessary titrant volume to achieve the equivalence point.
For potentiometric titration, the Gran plot is created by plotting...
1.1K
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

485
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
485
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

1.8K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

FLOWR.ROOT - A flow matching-based foundation model for joint multi-purpose structure-aware 3D ligand generation and affinity prediction.

Nature communications·2026
Same author

FLOWR: flow matching for structure-aware de novo, interaction- and fragment-based ligand generation.

Nature computational science·2026
Same author

A Computational Community Blind Challenge on Pan-Coronavirus Drug Discovery Data.

Journal of chemical information and modeling·2026
Same author

Flowr.root - A flow matching based foundation model for joint multi-purpose structure-aware 3D ligand generation and affinity prediction.

ArXiv·2025
Same author

Practically Significant Method Comparison Protocols for Machine Learning in Small Molecule Drug Discovery.

Journal of chemical information and modeling·2025
Same author

Advanced machine learning for innovative drug discovery.

Journal of cheminformatics·2025

Related Experiment Video

Updated: Jan 1, 2026

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0
07:41

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0

Published on: June 5, 2017

10.3K

Modeling Physico-Chemical ADMET Endpoints with Multitask Graph Convolutional Networks.

Floriane Montanari1, Lara Kuhnke1, Antonius Ter Laak1

  • 1Digital Technologies, Bayer AG, 13353 Berlin, Germany.

Molecules (Basel, Switzerland)
|December 28, 2019
PubMed
Summary

Machine learning accurately predicts drug compound properties like solubility and melting point. A multitask graph convolutional model enhances early compound prioritization in drug discovery, outperforming other methods.

Keywords:
ADMET predictionQSARgraph convolutional networksmultitask learningsolubility

Related Experiment Videos

Last Updated: Jan 1, 2026

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0
07:41

Modeling Fast-scan Cyclic Voltammetry Data from Electrically Stimulated Dopamine Neurotransmission Data Using QNsim1.0

Published on: June 5, 2017

10.3K

Area of Science:

  • Computational chemistry
  • Drug discovery
  • Machine learning

Background:

  • Physicochemical properties (e.g., logD, solubility, melting point) are crucial for assessing compound behavior in drug development.
  • These properties are routinely measured during early-stage drug discovery.
  • Bayer has amassed extensive in-house data on these properties.

Purpose of the Study:

  • To develop and evaluate a machine learning model for predicting physicochemical properties of new compounds.
  • To assess the performance of a multitask graph convolutional approach against other modeling techniques for predicting ADMET endpoints.
  • To enable early prioritization of synthesized compounds based on predicted properties.

Main Methods:

  • A multitask graph convolutional neural network (GCN) model was developed.
  • The GCN model was trained on a comprehensive dataset of Bayer's in-house physicochemical property data.
  • Performance was benchmarked against fully connected neural networks and single-task models for seven key endpoints.
  • Model adherence to the generalized solubility equation was assessed without explicit training on this constraint.

Main Results:

  • The multitask graph convolutional approach demonstrated highly competitive predictive performance, particularly for physicochemical ADMET endpoints.
  • The GCN model exhibited increased predictive accuracy compared to traditional fully connected neural networks and single-task models.
  • The model successfully predicted seven endpoints of interest with high efficacy.
  • The model implicitly followed the generalized solubility equation, indicating robust physical property understanding.

Conclusions:

  • Multitask graph convolutional networks offer a powerful and competitive approach for predicting physicochemical properties in drug discovery.
  • This predictive capability allows for earlier and more effective prioritization of drug candidates.
  • The developed model can guide compound selection before synthesis, accelerating the drug discovery pipeline.